Menu
GeneBe

2-147915329-A-G

Variant summary

Our verdict is Likely benign. Variant got -1 ACMG points: 1P and 2B. PP2BP4_Moderate

The NM_001616.5(ACVR2A):c.667A>G(p.Ile223Val) variant causes a missense change. The variant allele was found at a frequency of 0.00000411 in 1,459,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.0000041 ( 0 hom. )

Consequence

ACVR2A
NM_001616.5 missense

Scores

3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.72
Variant links:
Genes affected
ACVR2A (HGNC:173): (activin A receptor type 2A) This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -1 ACMG points.

PP2
Missense variant where missense usually causes diseases, ACVR2A
BP4
Computational evidence support a benign effect (MetaRNN=0.12628275).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ACVR2ANM_001616.5 linkuse as main transcriptc.667A>G p.Ile223Val missense_variant 5/11 ENST00000241416.12
ACVR2ANM_001278579.2 linkuse as main transcriptc.667A>G p.Ile223Val missense_variant 6/12
ACVR2ANM_001278580.2 linkuse as main transcriptc.343A>G p.Ile115Val missense_variant 5/11
ACVR2AXM_047446292.1 linkuse as main transcriptc.343A>G p.Ile115Val missense_variant 5/11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ACVR2AENST00000241416.12 linkuse as main transcriptc.667A>G p.Ile223Val missense_variant 5/111 NM_001616.5 P1P27037-1
ACVR2AENST00000404590.1 linkuse as main transcriptc.667A>G p.Ile223Val missense_variant 6/121 P1P27037-1
ACVR2AENST00000535787.5 linkuse as main transcriptc.343A>G p.Ile115Val missense_variant 5/112 P27037-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.00000399
AC:
1
AN:
250320
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
135276
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000545
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000411
AC:
6
AN:
1459622
Hom.:
0
Cov.:
31
AF XY:
0.00000551
AC XY:
4
AN XY:
726086
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000450
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000624
Hom.:
0

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 06, 2023The c.667A>G (p.I223V) alteration is located in exon 5 (coding exon 5) of the ACVR2A gene. This alteration results from a A to G substitution at nucleotide position 667, causing the isoleucine (I) at amino acid position 223 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.092
T
BayesDel_noAF
Benign
-0.37
Cadd
Benign
20
Dann
Uncertain
0.99
DEOGEN2
Benign
0.15
T;.;T
Eigen
Benign
-0.20
Eigen_PC
Benign
0.062
FATHMM_MKL
Uncertain
0.93
D
M_CAP
Benign
0.0086
T
MetaRNN
Benign
0.13
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.020
N;.;N
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.65
T
PROVEAN
Benign
-0.26
N;N;N
REVEL
Benign
0.055
Sift
Benign
0.29
T;T;T
Sift4G
Benign
0.52
T;T;T
Polyphen
0.0
B;.;B
Vest4
0.16
MutPred
0.30
Loss of ubiquitination at K226 (P = 0.0962);.;Loss of ubiquitination at K226 (P = 0.0962);
MVP
0.45
MPC
0.64
ClinPred
0.66
D
GERP RS
5.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.24
gMVP
0.48

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1489499469; hg19: chr2-148672898; API